VIJAYA - IntraDay Trade Analysis with Live Signals

Last Updated Time : 20 Dec 25, 07:04 am

IntraDay Trade Rating: 3.2

📊 Analysis: VIJAYA is trading at 995 ₹, slightly below DMA 50 (1,012 ₹) and DMA 200 (1,005 ₹), showing mild weakness. RSI at 46.0 indicates neutral-to-weak momentum, while MACD negative (-7.44) confirms bearish bias. Intraday volume (3,08,680) is slightly below weekly average (3,27,369), suggesting limited participation. Overall, the stock is a cautious candidate for intraday trading, with potential for small moves but not strong breakout momentum.

💰 Optimal Buy Price: 990–995 ₹ (near current support zone).

📈 Profit-Taking Levels: 1,008–1,012 ₹ (first resistance near DMA 50), 1,020–1,025 ₹ (second resistance).

⚠️ Stop-Loss: 985 ₹ (below support).

⏱️ If Already Holding: Exit intraday if price fails to sustain above 1,000 ₹ or if RSI dips below 45 with MACD continuing negative. Weak volume and inability to cross 1,008 ₹ should trigger exit to protect capital.

Positive

• ✅ Strong ROCE (20.2%) and ROE (18.1%) indicate efficient capital use.
• ✅ PAT improved from 38.8 Cr. to 42.7 Cr. quarter-on-quarter (+7.42%).
• ✅ DII holdings increased (+1.27%), reflecting domestic institutional support.

Limitation

• ⚠️ High P/E (68.6) compared to industry average (30.9), suggesting overvaluation.
• ⚠️ Negative MACD (-7.44) indicates bearish momentum.
• ⚠️ PEG ratio of 10.4 suggests expensive growth.
• ⚠️ Debt-to-equity ratio of 0.40 is relatively high.

Company Negative News

• 📉 Decline in FII holding (-1.29%) shows reduced foreign investor confidence.

Company Positive News

• 📈 PAT growth (+7.42%) quarter-on-quarter shows improving profitability.
• 📈 DII holdings increased (+1.27%), reflecting domestic institutional support.

Industry

• 🏭 Industry P/E at 30.9 is much lower than company’s P/E, showing sector is cheaper overall.
• 🏭 Healthcare/diagnostics sector remains demand-driven but valuations are stretched across leading players.

Conclusion

📌 VIJAYA is a cautious candidate for intraday trading with weak momentum. Buy near 990–995 ₹ with profit targets at 1,008–1,012 ₹ and 1,020–1,025 ₹. Maintain strict stop-loss at 985 ₹. If already holding, exit on failure to sustain above 1,000 ₹ or if RSI/MACD momentum weakens.

Would you like me to extend this into a peer benchmarking overlay so you can compare VIJAYA against other healthcare/diagnostic peers for intraday confirmation, or keep the focus on single-stock execution logic?